Selected research
Industry Research
Opioid Analgesics Industry Research Report 2026
Market perspective
The global Opioid Analgesics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Opioid Analgesics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Opioid Analgesics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Opioid Analgesics include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Opioid Analgesics market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Opioid Analgesics Market by Company
Assertio Holdings, Inc
Bausch Health
Boehringer Ingelheim International GmbH
Endo International Plc
F. Hoffmann-La Roche AG
Purdue Pharmaceuticals L.P.
Sanofi S.A.
Teva Pharmaceuticals
Abbott Laboratories
Bayer AG
GlaxoSmithKline plc
Pfizer Inc.
Novartis AG
Johnson & Johnson
Opioid Analgesics Segment by Type
Morphine
Methadone
OxyContin
Vicodin
Others
Opioid Analgesics Segment by Application
Surgical Pain
Neuropathic Pain
Cancer Pain
Others
Opioid Analgesics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Opioid Analgesics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Opioid Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Morphine
- Methadone
- OxyContin
- Vicodin
- Others
Applications
- Surgical Pain
- Neuropathic Pain
- Cancer Pain
- Others
Companies covered
- Assertio Holdings, Inc
- Bausch Health
- Boehringer Ingelheim International GmbH
- Endo International Plc
- F. Hoffmann-La Roche AG
- Purdue Pharmaceuticals L.P.
- Sanofi S.A.
- Teva Pharmaceuticals
- Abbott Laboratories
- Bayer AG
- GlaxoSmithKline plc
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Opioid Analgesics Market Size (2021-2032)
- 2.2.2 Global Opioid Analgesics Sales (2021-2032)
- 2.2.3 Global Opioid Analgesics Market Average Price (2021-2032)
- 2.3 Opioid Analgesics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Morphine
- 2.3.3 Methadone
- 2.3.4 OxyContin
- 2.3.5 Vicodin
- 2.3.6 Others
- 2.4 Opioid Analgesics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgical Pain
- 2.4.3 Neuropathic Pain
- 2.4.4 Cancer Pain
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Opioid Analgesics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Opioid Analgesics Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Opioid Analgesics Revenue of Manufacturers (2021-2026)
- 3.4 Global Opioid Analgesics Average Price by Manufacturers (2021-2026)
- 3.5 Global Opioid Analgesics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Opioid Analgesics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Opioid Analgesics, Product Type & Application
- 3.8 Global Manufacturers of Opioid Analgesics, Established Date
- 3.9 Global Opioid Analgesics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Assertio Holdings, Inc
- 4.1.1 Assertio Holdings, Inc Company Information
- 4.1.2 Assertio Holdings, Inc Business Overview
- 4.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
- 4.1.5 Assertio Holdings, Inc Recent Developments
- 4.2 Bausch Health
- 4.2.1 Bausch Health Company Information
- 4.2.2 Bausch Health Business Overview
- 4.2.3 Bausch Health Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bausch Health Opioid Analgesics Product Portfolio
- 4.2.5 Bausch Health Recent Developments
- 4.3 Boehringer Ingelheim International GmbH
- 4.3.1 Boehringer Ingelheim International GmbH Company Information
- 4.3.2 Boehringer Ingelheim International GmbH Business Overview
- 4.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
- 4.3.5 Boehringer Ingelheim International GmbH Recent Developments
- 4.4 Endo International Plc
- 4.4.1 Endo International Plc Company Information
- 4.4.2 Endo International Plc Business Overview
- 4.4.3 Endo International Plc Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Endo International Plc Opioid Analgesics Product Portfolio
- 4.4.5 Endo International Plc Recent Developments
- 4.5 F. Hoffmann-La Roche AG
- 4.5.1 F. Hoffmann-La Roche AG Company Information
- 4.5.2 F. Hoffmann-La Roche AG Business Overview
- 4.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
- 4.5.5 F. Hoffmann-La Roche AG Recent Developments
- 4.6 Purdue Pharmaceuticals L.P.
- 4.6.1 Purdue Pharmaceuticals L.P. Company Information
- 4.6.2 Purdue Pharmaceuticals L.P. Business Overview
- 4.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
- 4.6.5 Purdue Pharmaceuticals L.P. Recent Developments
- 4.7 Sanofi S.A.
- 4.7.1 Sanofi S.A. Company Information
- 4.7.2 Sanofi S.A. Business Overview
- 4.7.3 Sanofi S.A. Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
- 4.7.5 Sanofi S.A. Recent Developments
- 4.8 Teva Pharmaceuticals
- 4.8.1 Teva Pharmaceuticals Company Information
- 4.8.2 Teva Pharmaceuticals Business Overview
- 4.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
- 4.8.5 Teva Pharmaceuticals Recent Developments
- 4.9 Abbott Laboratories
- 4.9.1 Abbott Laboratories Company Information
- 4.9.2 Abbott Laboratories Business Overview
- 4.9.3 Abbott Laboratories Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
- 4.9.5 Abbott Laboratories Recent Developments
- 4.10 Bayer AG
- 4.10.1 Bayer AG Company Information
- 4.10.2 Bayer AG Business Overview
- 4.10.3 Bayer AG Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bayer AG Opioid Analgesics Product Portfolio
- 4.10.5 Bayer AG Recent Developments
- 4.11 GlaxoSmithKline plc
- 4.11.1 GlaxoSmithKline plc Company Information
- 4.11.2 GlaxoSmithKline plc Business Overview
- 4.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
- 4.11.5 GlaxoSmithKline plc Recent Developments
- 4.12 Pfizer Inc.
- 4.12.1 Pfizer Inc. Company Information
- 4.12.2 Pfizer Inc. Business Overview
- 4.12.3 Pfizer Inc. Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
- 4.12.5 Pfizer Inc. Recent Developments
- 4.13 Novartis AG
- 4.13.1 Novartis AG Company Information
- 4.13.2 Novartis AG Business Overview
- 4.13.3 Novartis AG Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Novartis AG Opioid Analgesics Product Portfolio
- 4.13.5 Novartis AG Recent Developments
- 4.14 Johnson & Johnson
- 4.14.1 Johnson & Johnson Company Information
- 4.14.2 Johnson & Johnson Business Overview
- 4.14.3 Johnson & Johnson Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
- 4.14.5 Johnson & Johnson Recent Developments
5 Global Opioid Analgesics Market Scenario by Region
- 5.1 Global Opioid Analgesics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Opioid Analgesics Sales by Region: 2021-2032
- 5.2.1 Global Opioid Analgesics Sales by Region: 2021-2026
- 5.2.2 Global Opioid Analgesics Sales by Region: 2027-2032
- 5.3 Global Opioid Analgesics Revenue by Region: 2021-2032
- 5.3.1 Global Opioid Analgesics Revenue by Region: 2021-2026
- 5.3.2 Global Opioid Analgesics Revenue by Region: 2027-2032
- 5.4 North America Opioid Analgesics Market Facts & Figures by Country
- 5.4.1 North America Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Opioid Analgesics Sales by Country (2021-2032)
- 5.4.3 North America Opioid Analgesics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Opioid Analgesics Market Facts & Figures by Country
- 5.5.1 Europe Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Opioid Analgesics Sales by Country (2021-2032)
- 5.5.3 Europe Opioid Analgesics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Opioid Analgesics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Opioid Analgesics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Opioid Analgesics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Opioid Analgesics Market Facts & Figures by Country
- 5.7.1 South America Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Opioid Analgesics Sales by Country (2021-2032)
- 5.7.3 South America Opioid Analgesics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Opioid Analgesics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Opioid Analgesics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Opioid Analgesics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Opioid Analgesics Sales by Type (2021-2032)
- 6.1.1 Global Opioid Analgesics Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Opioid Analgesics Sales Market Share by Type (2021-2032)
- 6.2 Global Opioid Analgesics Revenue by Type (2021-2032)
- 6.2.1 Global Opioid Analgesics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Opioid Analgesics Revenue Market Share by Type (2021-2032)
- 6.3 Global Opioid Analgesics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Opioid Analgesics Sales by Application (2021-2032)
- 7.1.1 Global Opioid Analgesics Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Opioid Analgesics Sales Market Share by Application (2021-2032)
- 7.2 Global Opioid Analgesics Revenue by Application (2021-2032)
- 7.2.1 Global Opioid Analgesics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Opioid Analgesics Revenue Market Share by Application (2021-2032)
- 7.3 Global Opioid Analgesics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Opioid Analgesics Value Chain Analysis
- 8.1.1 Opioid Analgesics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Opioid Analgesics Production Mode & Process
- 8.2 Opioid Analgesics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Opioid Analgesics Distributors
- 8.2.3 Opioid Analgesics Customers
9 Global Opioid Analgesics Analyzing Market Dynamics
- 9.1 Opioid Analgesics Industry Trends
- 9.2 Opioid Analgesics Industry Drivers
- 9.3 Opioid Analgesics Industry Opportunities and Challenges
- 9.4 Opioid Analgesics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst